Voyager Receives FDA IND Clearance for VY1706, First Gene Therapy Approach to Reducing Tau Production in the Brain for Alzheimer’s Disease
Go back to Voyager Receives FDA IND Clearance for VY1706, First Gene Therapy Approach to Reducing Tau Production in the Brain for Alzheimer’s Disease| (NASDAQ: VYGR) | Delayed: 3.72 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.72 | 52 Week High | $30.54 | |||
| Open | $3.69 | 52 Week Low | $8.12 | |||
| Day High | $3.82 | P/E | N/A | |||
| Day Low | $3.69 | EPS | $0.00 | |||
| Volume | 575,544 | |||||
